A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients
Stopped This protocol terminated prematurely on July 8, 2013 due to slow enrollment, not because of any safety issues or concerns.
Conditions
Interventions
Sponsor
Pfizer